CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash used in operating activities
Net loss	$ (48,472)	$ (22,982)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of intangible assets	2,535	3,053
Depreciation	4,871	5,147
Stock-based compensation expense	394	607
Amortization of financing fees	2,819	1,594
Deferred income taxes	29	(1,452)
Loss on extinguishment of debt	0	497
Other adjustments, net	941	(209)
Changes in operating assets and liabilities:
Accounts receivable, net	(4,952)	44,611
Inventory	(34,840)	(382)
Prepaid expenses and other assets	(103)	3,958
Accounts payable	62,105	(44,161)
Accrued expenses	(42,759)	11,106
Other noncurrent liabilities	(4,046)	(8,981)
Net cash used in operating activities	(61,478)	(7,594)
Cash provided by (used in) investing activities
Capital expenditures	(1,968)	(2,402)
Return of investment in joint venture	2,263	0
Proceeds from corporate-owned life insurance	0	930
Other investing activities, net	103	60
Net cash provided by (used in) investing activities	398	(1,412)
Cash provided by financing activities
Repayments of long-term debt and lease liabilities	(380)	(55,290)
Proceeds from debt financings	51,309	0
Repayment of short-term financings	(1,180)	0
Proceeds from revolving line of credit	0	180,298
Repayments of revolving line of credit	0	(89,826)
Payments of deferred financing costs	(3,162)	(1,970)
Other financing activities, net	(42)	58
Net cash provided by financing activities	46,545	33,270
Net (decrease) increase in cash, cash equivalents, and restricted cash	(14,535)	24,264
Cash, cash equivalents, and restricted cash at beginning of the year	24,267	3
Cash, cash equivalents, and restricted cash at end of the year	9,732	24,267
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets
Cash and cash equivalents	6,255	20,968
Restricted cash	3,477	3,299
Total cash, cash equivalents, and restricted cash	$ 9,732	$ 24,267